Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative sublingual misoprostol for reducing blood loss during total abdominal hysterectomy
IRCT20180821040844N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in benign gynecological disease comparing Misoprostol with Placebo comparator (2 arms). Primary endpoints: Intraoperative blood loss and Postoperative hemoglobin. Started Nov 2017; status: completed.
02
Drugs
misoprostol
03
Conditions
benign gynecological disease
Beyond the preview
Go deeper on IRCT20180821040844N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180821040844N1.